Drug Shortages: Health, Security, and Policy Perspectives

$115.00

Duncan Sawyer (Editor)

Series: Pharmacology – Research, Safety Testing and Regulation
BISAC: MED072000

Shortages of critical medications continue to rise—including drugs used in hospital emergency rooms and to treat cancer, prescription medications, and even common over-the-counter treatments like children’s cold and flu medicine. The number of active drug shortages in the U.S. reached a peak of 295 at the end of 2022. They are caused by a number of factors, including economic drivers, insufficient supply chain visibility, and a continued U.S. overreliance on both foreign and geographically concentrated sources for medications and their raw materials. These shortages have cascading effects on patient care, causing delays in treatment, increasing the risk of medication errors, and requiring the use of less effective alternative treatments. Hospitals have also experienced increased costs, medication waste, and limited staffing capacity to address and remedy shortages. This book will examine the very serious and growing problem of prescription drug shortages.

somdn_product_page

Table of Contents

Preface

Chapter 1. Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains
Committee on Energy and Commerce

Chapter 2. Drug Shortage Health and National Security Risks: Underlying Causes and Needed Reforms
Committee on Homeland Security and Governmental Affairs

Chapter 3. Short Supply: The Health and National Security Risks of Drug Shortages
Committee on Homeland Security and Governmental Affairs

Chapter 4. The Federal Role in Addressing the Adderall Drug Shortage
Lisa N. Sacco and Hassan Z. Sheikh

Index

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!